GABAA receptors modulate cannabinoid-evoked hypothermia

Pharmacology Biochemistry and Behavior

Volumn 78, Issue 1, 2004, Pages 83-91

  Rawls, S M ^a   Tallarida, R J ^b   Kon, D A ^b   Geller, E B ^b   Adler, Martin W ^b  

^a TEMPLE UNIVERSITY   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bicuculline; Cannabinoid; GABA; Hypothermia; SCH 50911; WIN 55212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 5,5 DIMETHYL 2 MORPHOLINEACETIC ACID; BACLOFEN; BICUCULLINE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; MUSCIMOL; RIMONABANT; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; CANNABINOID; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DRUG ACTIVITY; GABAERGIC SYSTEM; HYPOTHERMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR SENSITIVITY; THERMOREGULATION; ANIMAL; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CANNABINOIDS; GABA AGONISTS; GABA ANTAGONISTS; HYPOTHERMIA; MALE; MORPHOLINES; NAPHTHALENES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTORS, GABA-A;

EID: 2442697405     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2004.02.006     Document Type: Article

References (61)

1. Anderson J.J., DiMicco J.A. The use of microdialysis for studying the regional effects of pharmacological manipulation on extracellular levels of amino acids - some methodological aspects. Life Sci. 51:1992;623-630
2. Azad S.C., Marsicano G., Eberlein I., Putzke J., Zieglgansberger W., Spanagel R., et al. Differential role of the NO pathway on delta(9)-THC-induced central nervous system effects in the mouse. Eur. J. Neurosci. 13:2001;561-568
3. Banerjee S.P., Snyder S.H., Mechoulam R. Cannabinoids: influence on neurotransmitter uptake in rat brain synaptosomes. J. Pharmacol. Exp. Ther. 194:1975;74-81
4. Caulfield M.P., Brown D.A. Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism. Br. J. Pharmacol. 106:1992;231-232
5. Chebib M., Johnston G.A. The 'ABC' of GABA receptors: a brief review. Clin. Exp. Pharmacol. Physiol. 26:1999;937-940
6. Compton D.R., Gold L.H., Ward S.J., Balster R.L., Martin B.R. Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther. 263:1992;1118-1126
7. Compton D.R., Aceto M.D., Lowe J., Martin B.R. In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity. J. Pharmacol. Exp. Ther. 277:1996;586-594
8. Davies J.A., Graham J.D. The mechanism of action of delta 9-tetrahydrocannabinol on body temperature in mice. Psychopharmacology. 69:1980;299-305
9. Davies S.N., Pertwee R.G., Riedel G. Functions of cannabinoid receptors in the hippocampus. Neuropharmacology. 42:2002;993-1007
10. de Miguel R., Romero J., Munoz R.M., Garcia-Gil L., Gonzalez S., Villanua M.A., et al. Effects of cannabinoids on prolactin and gonadotrophin secretion: involvement of changes in hypothalamic gamma-aminobutyric acid (GABA) inputs. Biochem. Pharmacol. 56:1998;1331-1338
11. Dragic T., Litwin V., Allaway G.P., Martin S.R., Huang Y.X., Nagashima K.A., et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381:1996;667-673
12. Drummer H.L., Woolley D.E. Toxicokinetics of Ro 5-4864, lindane and picrotoxin compared. Pharmacol. Biochem. Behav. 38:1991;235-242
13. Ferraro L., Tomasini M.C., Cassano T., Bebe B.W., Siniscalchi A., O'Connor W.T., et al. Cannabinoid receptor agonist WIN 55, 212-2 inhibits rat cortical dialysate gamma-aminobutyric acid levels. J. Neurosci. Res. 66:2001;298-302
14. Fitton A.G., Pertwee R.G. Changes in body temperature and oxygen consumption rate of conscious mice produced by intrahypothalamic and intracerebroventricular injections of delta 9-tetrahydrocannabinol. Br. J. Pharmacol. 75:1982;409-414
15. Gessa G.L., Casu M.A., Carta G., Mascia M.S. Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR 141716A. Eur. J. Pharmacol. 355:1998;119-124
16. Han S.K., Chong W., Li L.H., Lee I.S., Murase K., Ryu P.D. Noradrenaline excites and inhibits GABAergic transmission in parvocellular neurons of rat hypothalamic paraventricular nucleus. J. Neurophysiol. 87:2002;2287-2296
17. Herbison A.E., Heavens R.P., Dyer R.G. Oestrogen modulation of excitatory A1 noradrenergic input to rat medial preoptic gamma aminobutyric acid neurones demonstrated by microdialysis. Neuroendocrinology. 52:1990;161-168
18. Howlett A.C. Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol. 35:1995;607-634
19. Huang C.C., Lo S.W., Hsu K.S. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons. J. Physiol. 532:2001;731-748
20. Ipponi A., Lamberti C., Medica A., Bartolini A., Malmberg-Aiello P. Tiagabine antinociception in rodents depends on GABA(B) receptor activation: parallel antinociception testing and medial thalamus GABA microdialysis. Eur. J. Pharmacol. 368:1999;205-211
21. Ishac E.J., Jiang L., Lake K.D., Varga K., Abood M.E., Kunos G. Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br. J. Pharmacol. 118:1996;2023-2028
22. Jha S.K., Islam F., Mallick B.N. GABA exerts opposite influence on warm and cold sensitive neurons in medial preoptic area in rats. J. Neurobiol. 48:2001;291-300
23. Jha S.K., Yadav V., Mallick B.N. GABA-A receptors in mPOAH simultaneously regulate sleep and body temperature in freely moving rats. Pharmacol. Biochem. Behav. 70:2001;115-121
24. Kathmann M., Bauer U., Schlicker E., Gothert M. Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 359:1999;466-470
25. Ledent C., Valverde O., Cossu G., Petitet F., Aubert J.-F., Beslot F., et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science. 283:1999;401-404
26. Lin M.T., Shian L.R., Leu S.Y. Effects of hypothalamic noradrenaline depletion with 6-hydroxydopamine on the body temperature regulation of the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 325:1984;131-135
27. Lin M.T., Chern Y.F., Chen S.Y. Depletion of noradrenaline in the hypothalamus reduces the febrile responses induced by prostaglandin E2, thyrotropin-releasing hormone and beta-endorphin in rats. Neuropharmacology. 24:1985;1039-1042
28. Mackie K., Hille B. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. U. S. A. 89:1992;3825-3829
29. Malone D.T., Taylor D.A. Modulation of delta9-tetrahydrocannabinol- induced hypothermia by fluoxetine in the rat. Br. J. Pharmacol. 124:1998;1419-1424
30. Marsicano G., Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur. J. Neurosci. 11:1999;4213-4225
31. Martin B.R., Compton D.R., Thomas B.F., Prescott W.R., Little P.J., Razdan R.K., et al. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacol. Biochem. Behav. 40:1991;471-478
32. Matejovska I., Veliskova J., Velisek L. Bicuculline-induced rhythmic EEG episodes: gender differences and the effects of ethosuximide and baclofen treatment. Epilepsia. 39:1998;1243-1252
33. McGregor I.S., Dastur F.N., McLellan R.A., Brown R.E. Cannabinoid modulation of rat pup ultrasonic vocalizations. Eur. J. Pharmacol. 313:1996;43-49
34. Moldrich G., Wenger T. Localization of the CB1 cannabinoid receptor in the rat brain. An immunohistochemical study. Peptides. 21:2000;1735-1742
35. Nakayama T. Thermosensitive neurons in the brain. Jpn. J. Physiol. 35:1985;375-389
36. Nava F., Carta G., Gessa G.L. Permissive role of dopamine D(2) receptors in the hypothermia induced by delta(9)-tetrahydrocannabinol in rats. Pharmacol. Biochem. Behav. 66:2000;183-187
37. Niederhoffer N., Szabo B. Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation. Br. J. Pharmacol. 12:1999;457-466
38. Okamura H., Abitbol M., Julien J.F., Dumas S., Berod A., Geffard M., et al. Neurons containing messenger RNA encoding glutamate decarboxylase in rat hypothalamus demonstrated by in situ hybridization, with special emphasis on cell groups in medial preoptic area, anterior hypothalamic area and dorsomedial hypothalamic nucleus. Neuroscience. 39:1990;675-699
39. Pertwee R.G., Greentree S.G. Delta-9-tetrahydrocannabinol-induced catalepsy in mice is enhanced by pretreatment with flurazepam or chlordiazepoxide. Neuropharmacology. 27:1988;485-491
40. Pertwee R.G., Greentree S.G., Swift P.A. Drugs which stimulate or facilitate central GABAergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in mice. Neuropharmacology. 27:1988;1265-1270
41. Pertwee R.G., Browne S.E., Ross T.M., Stretton C.D. An investigation of the involvement of GABA in certain pharmacological effects of delta-9-tetrahydrocannabinol. Pharmacol. Biochem. Behav. 40:1991;581-585
42. Petroff O.A. GABA and glutamate in the human brain. Neuroscientist. 8:2002;562-573
43. Phillis B.D., Ong J., White J.M., Bonnielle C. Modification of D-amphetamine-induced responses by baclofen in rats. Psychopharmacology. 153:2001;277-284
44. Pistis M., Ferraro L., Pira L., Flore G., Tanganelli S., Gessa G.L., et al. Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study. Brain Res. 948:2002;155-158
45. Rawls S.M., Cabassa J., Geller E.B., Adler M.W. CB1 receptors in the preoptic anterior hypothalamic nucleus regulate WIN 55212-2-induced hypothermia. J. Pharmacol. Exp. Ther. 301:2002;963-968
46. Rawls S.M., Cowan A., Tallarida R.J., Geller E.B., Adler M.W. N-methyl-D-aspartate antagonists and WIN 55212-2 [4, 5-dihydro-2-methyl-4(4- morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3, 2, 1-i, j]quinolin-6-one], a cannabinoid agonist, interact to produce synergistic hypothermia. J. Pharmacol. Exp. Ther. 303:2002;395-402
47. Rawls S.M., Tallarida R.J., Geller E.B., Adler M.W. WIN 55212-2, a cannabinoid agonist, and U-50, 488H, a kappa opioid agonist, produce synergistic hypothermia. International Narcotics Research Conference Abstracts. vol. S52:2002
48. Rawls S.M., Tallarida R.J., Geller E.B., Adler M.W. L-NAME, a nitric oxide synthase inhibitor, and WIN 55212-2, a cannabinoid agonist, interact to evoke synergistic hypothermia. J. Pharmacol. Exp. Ther. 380:2004;780-786
49. Richards D.A., Bowery N.G. Comparative effects of the GABA uptake inhibitors, tiagabine and NNC-711, on extracellular GABA levels in the rat ventrolateral thalamus. Neurochem. Res. 21:1996;135-140
50. Romero J., de Miguel R., Ramos J.A., Fernandez-Ruiz J.J. The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake. Life Sci. 62:1998;351-363
51. Sancibrian M., Serrano J.S., Minano F.J. Opioid and prostaglandin mechanisms involved in the effects of GABAergic drugs on body temperature. Gen. Pharmacol. 22:1991;259-262
52. Schlicker E., Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol. Sci. 22:2001;565-572
53. A-benzodiazepine receptor subtypes. Adv. Biochem. Psychopharmacol. 47:1992;155-162
54. Singh P.P., Das P.K. Role of catecholamines in the hypothermic activity of cannabis in albino rats. Psychopharmacology. 50:1976;199-204
55. Steger R.W., Murphy L.L., Bartke A., Smith M.S. Effects of psychoactive and nonpsychoactive cannabinoids on the hypothalamic-pituitary axis of the adult male rat. Pharmacol. Biochem. Behav. 37:1990;299-302
56. Tzavara E.T., Perry K.W., Rodriguez D.E., Bymaster F.P., Nomikos G.G. The cannabinoid CB(1) receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus. Eur. J. Pharmacol. 426:2001;R3-R4
57. Vizi E.S., Katona I., Freund T.F. Evidence for presynaptic cannabinoid CB(1) receptor-mediated inhibition of noradrenaline release in the guinea pig lung. Eur. J. Pharmacol. 431:2001;237-244
58. Wang Y.F., Shibuya I., Kabashima N., Setiadji V.S., Isse T., Ueta Y., et al. Inhibition of spontaneous inhibitory postsynaptic currents (IPSC) by noradrenaline in rat supraoptic neurons through presynaptic alpha2- adrenoceptors. Brain Res. 807:1998;61-69
59. Wiley J.L., Barrett R.L., Lowe J., Balster R.L., Martin B.R. Discriminative stimulus effects of CP 55, 940 and structurally dissimilar cannabinoids in rats. Neuropharmacology. 34:1995;669-676
60. Yakimova K., Ovtcharov R. Central temperature effects of the transmitter amino acids. Acta Physiol. Pharmacol. Bulg. 15:1989;50-54
61. B receptor sites involvement in rat thermoregulation. Gen. Pharmacol. 19:1988;223-226